Bioethics Ltd
Bioethics, Ltd. does not have significant operations. It intends to seek investigate and, if warranted, acquire an interest in a business opportunity. Bioethics, Ltd. was incorporated in 1990 and is based in Ogden, Utah.
Bioethics Ltd (BOTH) - Total Assets
Latest total assets as of June 2025: $14.66K USD
Based on the latest financial reports, Bioethics Ltd (BOTH) holds total assets worth $14.66K USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Bioethics Ltd - Total Assets Trend (1998–2025)
This chart illustrates how Bioethics Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Bioethics Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Bioethics Ltd's total assets of $14.66K consist of 100.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 100.0% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1998–2025)
This chart illustrates how Bioethics Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Bioethics Ltd's current assets represent 100.0% of total assets in 2025, unchanged from 100.0% in 1998.
- Cash Position: Cash and equivalents constituted 100.0% of total assets in 2025, the same as 100.0% in 1998.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1998.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Bioethics Ltd Competitors by Total Assets
Key competitors of Bioethics Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
464680
KQ:464680
|
Korea | ₩31.23 Billion |
|
Cartesian Growth Corporation III Unit
NASDAQ:CGCTU
|
USA | $281.56 Million |
|
Azure Holding Group Corp
PINK:AZRH
|
USA | $16.92 Million |
|
Constellation Capital Corp.
V:CNST-P
|
Canada | CA$627.53K |
|
Little Fish Acquisition I Corp.
V:LILL-P
|
Canada | CA$56.48K |
|
Hana 30 Special Purpose Acquisition Company
KQ:469880
|
Korea | ₩17.89 Billion |
|
Chicane Capital I Corp.
V:CCIC-P
|
Canada | CA$199.07K |
|
Cuspis Capital II Ltd
V:CCII-P
|
Canada | CA$1.51 Million |
Bioethics Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Bioethics Ltd generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Bioethics Ltd is currently not profitable relative to its asset base.
Bioethics Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.02 | 0.01 | 0.00 |
| Quick Ratio | 0.02 | 0.01 | 0.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-931.22K | $ -851.85K | $ -424.28K |
Bioethics Ltd - Advanced Valuation Insights
This section examines the relationship between Bioethics Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2020.95 |
| Latest Market Cap to Assets Ratio | 1.25 |
| Asset Growth Rate (YoY) | 0.0% |
| Total Assets | $14.66K |
| Market Capitalization | $18.36K USD |
Valuation Analysis
Above Book Valuation: The market values Bioethics Ltd's assets above their book value (1.25 x), reflecting positive investor sentiment about the company's future prospects.
Slight Asset Contraction: Bioethics Ltd's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Bioethics Ltd (1998–2025)
The table below shows the annual total assets of Bioethics Ltd from 1998 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $14.66K | 0.00% |
| 2024-12-31 | $14.66K | +10526.09% |
| 2023-12-31 | $138.00 | -53.22% |
| 2022-12-31 | $295.00 | -59.81% |
| 2021-12-31 | $734.00 | -17.81% |
| 2020-12-31 | $893.00 | -90.37% |
| 2019-12-31 | $9.27K | -71.46% |
| 2018-12-31 | $32.49K | +575.99% |
| 2017-12-31 | $4.81K | -92.85% |
| 2016-12-31 | $67.27K | -9.89% |
| 2015-12-31 | $74.65K | +290.16% |
| 2014-12-31 | $19.13K | +5229.81% |
| 2013-12-31 | $359.00 | -92.03% |
| 2012-12-31 | $4.50K | -35.54% |
| 2011-12-31 | $6.99K | +56.60% |
| 2010-12-31 | $4.46K | +37.03% |
| 2009-12-31 | $3.26K | +79.15% |
| 2008-12-31 | $1.82K | -85.49% |
| 2007-12-31 | $12.53K | +83.09% |
| 2006-12-31 | $6.84K | -45.36% |
| 2005-12-31 | $12.52K | +1061.69% |
| 2004-12-31 | $1.08K | -81.65% |
| 2003-12-31 | $5.88K | -50.07% |
| 2002-12-31 | $11.77K | -31.95% |
| 2001-12-31 | $17.29K | -27.04% |
| 2000-12-31 | $23.70K | -20.47% |
| 1999-12-31 | $29.80K | -16.20% |
| 1998-12-31 | $35.56K | -- |